BIONANOTECH LLC

Biotech · Private

protein purification resins based on nanomaterials for immobilized metal affinity chromatography (IMAC)

Grants
$225K
1 award
Sector median: 1
Raised
—
No Form D on record
Contracts
—
No federal contracts on record
Patents
2
0 granted · 2 pending
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Federal grantNational Science Foundation · Phase I · SBIR Phase I: A New Class of Immobilized Metal Affinity Chromatography Resins$225,000
Federal grant · SBIR/STTR

Peer position

Biotech · 4373 companies · ranked on federal contract value
Biotech companies ranked by federal contract value
#CompanyContractsDisclosed equity
2639YOUNG THERAPEUTICS, LLC——
2640Avant Sciences, Inc.—$175K
2641Renova Therapeutics, Inc.—$167K
2642BIONANOTECH LLC——
2643GREFFEX, INC.—$155K
2644RITROVA THERAPEUTICS INC.—$150K
2645SYMMETRIC COMPUTING, INC.——

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Patents

USPTO · 0 granted of 2
  • Tangential Flow Filtration And Nanoresinsapplication
  • Nanoligands For Affinity Chromatograph And Methods Of Use Thereforeapplication

Regulatory activity · Biotech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.